Taysha Gene Therapies, Inc. revenue breakdown overview

Taysha Gene Therapies, Inc. revenue for the last year amounted to 15.50 M USD, the most of which — 15.45 M USD — came from its highest performing source at the moment, Adeno-Associated Viruses-based Gene Therapies, the year earlier bringing 2.50 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Taysha Gene Therapies, Inc. 15.45 M USD, and the year before that — 2.50 M USD.